Rain Oncology’s Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data.
Benzinga’s Top Ratings Upgrades, Downgrades For May 23, 2023
Upgrades MoffettNathanson upgraded the previous rating for Zoom Video Communications Inc (NASDAQ:ZM) from Underperform to Market Perform. Zoom…
iPhones or iFrowns? Analyst Predicts Dwindling Shipments Despite Potent iPhone ASPs
Apple Inc (NASDAQ: AAPL) stock is trading lower Monday after Loop Capital downgraded the
Benzinga’s Top Ratings Upgrades, Downgrades For May 22, 2023
Upgrades For Avidity Biosciences Inc (NASDAQ:RNA), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In…
Foot Locker Stock Is Sliding: What’s Going On?
Foot Locker Inc (NYSE: FL) shares are trading lower Monday after several analysts cut price targets on the stock following the company's disappointing earnings results.
Noodles & Co Stock Tumbles: CFO Resigns, Analyst Professed A Distaste On Low Traffic
Stephens & Co analyst Joshua Long downgraded Noodles & Co (NASDAQ:NDLS) to Equal-Weight from Overweight at a reduced price target of $5…
Disney’s Stock Faces The Unhappiest Place On Earth: A Downgrade
There are too many structural and macro headwinds at The Walt Disney Company (NYSE:DIS) to support its previous…
Benzinga’s Top Ratings Upgrades, Downgrades For May 19, 2023
Upgrades For MaxLinear Inc (NASDAQ:MXL), Exane BNP Paribas upgraded the previous rating of Underperform to Neutral. MaxLinear earned…
Benzinga’s Top Ratings Upgrades, Downgrades For May 18, 2023
Upgrades According to CIBC, the prior rating for BlackBerry Ltd (NYSE:BB) was changed from Underperformer to Neutral. In…
Analyst Gives A Thumbs Up To Magellan Midstream Partners-ONEOK Merger, Calls It Positive
RBC Capital Markets analyst Elvira Scotto increased the price target of Magellan Midstream Partners LP (NYSE:MMP) to $66 from $59 and downgraded to…